Radnor Capital Management’s Elevance Health ELV Stock Holding History

Radnor Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.8M	Sell	7,235 -135	-2%	-$50.1K	0.39%	65
2026 Q1	$2.16M	Hold	7,370	–	–	0.32%	82
2025 Q4	$2.58M	Sell	7,370 -160	-2%	-$54.1K	0.38%	70
2025 Q3	$2.43M	Hold	7,530	–	–	0.37%	69
2025 Q2	$2.93M	Sell	7,530 -90	-1%	-$36.2K	0.47%	53
2025 Q1	$3.31M	Buy	7,620 +55	+0.7%	+$22.1K	0.56%	41
2024 Q4	$2.79M	Sell	7,565 -425	-5%	-$178K	0.47%	52
2024 Q3	$4.16M	Buy	7,990 +330	+4%	+$176K	0.62%	38
2024 Q2	$4.15M	Buy	7,660 +290	+4%	+$153K	1.27%	13
2024 Q1	$3.82M	Hold	7,370	–	–	0.65%	31
2023 Q4	$3.48M	Sell	7,370 -340	-4%	-$157K	0.65%	28
2023 Q3	$3.36M	Buy	+7,710	New	+$3.5M	0.67%	29

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Radnor Capital Management's ELV Position: Q2 2026 in Review

Radnor Capital Management reduced its Elevance Health (ELV) stake by 1.8% in Q2 2026, selling an estimated $50.1K and leaving 7,235 shares worth $2.8M. The position accounts for 0.39% of the portfolio, ranked #65.

Radnor Capital Management first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.16M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Radnor Capital Management held 7,235 shares of Elevance Health worth $2.8M as of Q2 2026.
Radnor Capital Management sold 135 Elevance Health shares in Q2 2026, an estimated $50.1K.
Elevance Health made up 0.39% of Radnor Capital Management's portfolio in Q2 2026, its #65 holding.
Radnor Capital Management first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
Radnor Capital Management's Elevance Health position peaked at $4.16M in Q3 2024.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.